Eiichiro Satake, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Nephropathies | 10 | 2024 | 973 | 1.290 |
Why?
|
Kidney Failure, Chronic | 9 | 2024 | 2471 | 1.140 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2024 | 3441 | 0.710 |
Why?
|
Inositol | 1 | 2016 | 215 | 0.490 |
Why?
|
Glucose Tolerance Test | 2 | 2016 | 1179 | 0.430 |
Why?
|
MicroRNAs | 5 | 2024 | 3812 | 0.430 |
Why?
|
Hyperglycemia | 2 | 2021 | 1376 | 0.430 |
Why?
|
Mesenchymal Stem Cells | 1 | 2021 | 1642 | 0.360 |
Why?
|
Body Fat Distribution | 1 | 2010 | 245 | 0.320 |
Why?
|
Hypercalcemia | 2 | 2013 | 423 | 0.310 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2022 | 12143 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2243 | 0.280 |
Why?
|
Neuroblastoma | 2 | 2023 | 1250 | 0.240 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2021 | 584 | 0.230 |
Why?
|
Glomerulonephritis, IGA | 1 | 2023 | 63 | 0.210 |
Why?
|
Disease Progression | 10 | 2024 | 13502 | 0.200 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 56 | 0.190 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2020 | 60 | 0.180 |
Why?
|
Renal Insufficiency | 2 | 2024 | 809 | 0.170 |
Why?
|
Adipogenesis | 2 | 2013 | 368 | 0.170 |
Why?
|
Albuminuria | 2 | 2020 | 657 | 0.170 |
Why?
|
Focal Adhesions | 1 | 2018 | 115 | 0.150 |
Why?
|
Telomere-Binding Proteins | 1 | 2018 | 119 | 0.140 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2018 | 219 | 0.130 |
Why?
|
Kidney | 5 | 2023 | 7049 | 0.130 |
Why?
|
Nerve Growth Factors | 1 | 2018 | 563 | 0.120 |
Why?
|
Japan | 2 | 2016 | 1371 | 0.120 |
Why?
|
Waist Circumference | 2 | 2015 | 934 | 0.110 |
Why?
|
Adaptor Protein Complex sigma Subunits | 1 | 2013 | 10 | 0.110 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2013 | 42 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 789 | 0.110 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2176 | 0.100 |
Why?
|
Carbenoxolone | 1 | 2011 | 8 | 0.100 |
Why?
|
Proteinuria | 1 | 2015 | 607 | 0.100 |
Why?
|
Genetic Variation | 2 | 2024 | 6581 | 0.100 |
Why?
|
Proteomics | 5 | 2024 | 3845 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 629 | 0.090 |
Why?
|
Adult | 13 | 2024 | 221148 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3447 | 0.090 |
Why?
|
Lipids | 2 | 2013 | 3340 | 0.090 |
Why?
|
Cholecystokinin | 1 | 2011 | 117 | 0.090 |
Why?
|
Calcium, Dietary | 1 | 2013 | 529 | 0.090 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 61 | 0.090 |
Why?
|
Hyperphagia | 1 | 2011 | 139 | 0.090 |
Why?
|
Peptide YY | 1 | 2011 | 136 | 0.090 |
Why?
|
Male | 17 | 2024 | 360736 | 0.090 |
Why?
|
Down-Regulation | 2 | 2021 | 2918 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4391 | 0.090 |
Why?
|
Female | 19 | 2024 | 392581 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4354 | 0.080 |
Why?
|
Humans | 26 | 2024 | 761423 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3576 | 0.080 |
Why?
|
Adipocytes | 2 | 2013 | 1194 | 0.080 |
Why?
|
Ghrelin | 1 | 2011 | 252 | 0.080 |
Why?
|
Glucocorticoids | 2 | 2010 | 2161 | 0.080 |
Why?
|
Intra-Abdominal Fat | 2 | 2011 | 612 | 0.080 |
Why?
|
Milk, Human | 1 | 2013 | 484 | 0.080 |
Why?
|
Abdominal Fat | 1 | 2010 | 221 | 0.080 |
Why?
|
Apoptosis | 1 | 2024 | 9488 | 0.080 |
Why?
|
Middle Aged | 9 | 2024 | 220826 | 0.070 |
Why?
|
Up-Regulation | 2 | 2021 | 4124 | 0.070 |
Why?
|
Obesity, Abdominal | 1 | 2011 | 374 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 2011 | 580 | 0.070 |
Why?
|
Blood Proteins | 2 | 2024 | 1180 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20093 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5840 | 0.060 |
Why?
|
Furosemide | 1 | 2006 | 170 | 0.060 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2010 | 538 | 0.060 |
Why?
|
Calcitonin | 1 | 2006 | 329 | 0.060 |
Why?
|
Fibrosis | 2 | 2023 | 2048 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 832 | 0.060 |
Why?
|
Williams Syndrome | 1 | 2006 | 193 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2006 | 587 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6391 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1902 | 0.050 |
Why?
|
Dietary Fats | 1 | 2010 | 1994 | 0.050 |
Why?
|
Infant Formula | 2 | 2013 | 193 | 0.050 |
Why?
|
Endostatins | 1 | 2022 | 168 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10762 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41446 | 0.050 |
Why?
|
Prognosis | 4 | 2020 | 29620 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2010 | 2637 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4347 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2011 | 3312 | 0.040 |
Why?
|
Mass Screening | 1 | 2015 | 5428 | 0.040 |
Why?
|
Signal Transduction | 2 | 2024 | 23441 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1229 | 0.040 |
Why?
|
Kidney Tubules, Proximal | 1 | 2021 | 383 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2022 | 584 | 0.040 |
Why?
|
Child | 4 | 2016 | 80162 | 0.040 |
Why?
|
Ductus Arteriosus | 1 | 2018 | 44 | 0.040 |
Why?
|
Age Factors | 2 | 2015 | 18400 | 0.040 |
Why?
|
Aged | 4 | 2024 | 169235 | 0.040 |
Why?
|
New England | 1 | 2020 | 1053 | 0.040 |
Why?
|
Animals | 6 | 2021 | 168441 | 0.040 |
Why?
|
Body Weight | 3 | 2011 | 4618 | 0.030 |
Why?
|
Risk Factors | 5 | 2024 | 74167 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2011 | 2677 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1960 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2021 | 1023 | 0.030 |
Why?
|
Gene Expression | 2 | 2021 | 7584 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2013 | 34 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 102 | 0.030 |
Why?
|
3T3-L1 Cells | 1 | 2013 | 209 | 0.030 |
Why?
|
Infant | 3 | 2013 | 36205 | 0.030 |
Why?
|
Vitamin D | 1 | 2006 | 3301 | 0.030 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenases | 1 | 2010 | 5 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 12970 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4140 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22168 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1886 | 0.020 |
Why?
|
Lipogenesis | 1 | 2011 | 214 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2011 | 8179 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1738 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30045 | 0.020 |
Why?
|
Adolescent | 3 | 2011 | 88313 | 0.020 |
Why?
|
Insulin | 2 | 2013 | 6602 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2460 | 0.020 |
Why?
|
Biological Transport | 1 | 2011 | 2092 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12720 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2254 | 0.020 |
Why?
|
Child Development | 1 | 2018 | 2305 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2011 | 941 | 0.020 |
Why?
|
Dexamethasone | 1 | 2013 | 1947 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15498 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81509 | 0.010 |
Why?
|
Rats | 2 | 2011 | 23742 | 0.010 |
Why?
|
Eating | 1 | 2011 | 1538 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14599 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6215 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54415 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10548 | 0.010 |
Why?
|
Body Composition | 1 | 2011 | 2422 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8487 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2011 | 3612 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2011 | 3187 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26212 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5970 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12796 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26112 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12951 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80582 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18247 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 64651 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2010 | 58956 | 0.000 |
Why?
|
Young Adult | 1 | 2010 | 59207 | 0.000 |
Why?
|